//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
In part 2 of our MASLD series, Sven Francque outlines that resmetirom is now approved in F2-F3 fibrosis in parts of Europe, semaglutide has produced positive phase 3 data in MASH, and the guideline is being updated. Tune in now: 🔗 https://bit.ly/44R97K3
We’ve explored how much of this burden is preventable – from the role of nutrition and ultra-processed foods 🍽️ to the life-saving potential of early detection through screening 🩺
Thank you to everyone who joined us in Vienna for the joint meeting of National Societies Forum & Meeting of Members! From interactive workshop sessions to strategic exchanges – your engagement & insights are what drive the UEG community forward. Until next time! 💚 #weareUEG
#WDHD2026 marks a moment – but not the end of the conversation. What follows matters. Hear from @joostphdrenth.bsky.social​​ and Roos E. Pouw on what must happen next – ensuring evidence drives real change to reduce the burden of digestive diseases & cancers across Europe 🛡️
On #WDHD2026, listen to our recent policy webinar exploring whether the EU Safe Hearts Plan can improve digestive health – and the changes needed to drive progress on prevention. Watch the full discussion on YouTube: https://bit.ly/3Rb2vTx or Gutflix: https://bit.ly/4fn17Hi
19d
22d
@alexsworking.bsky.social​ #DigestiveHealthMonth #EUNewsline
This #DigestiveHealthMonth, we’ve taken a closer look at one of Europe’s most pressing public health challenges – the growing burden of digestive diseases and cancers 📊 – and what the evidence tells us about how to respond 👇
3d
24d
24d
UEG President Joost P.H. Drenth is at #EASLCongress 2026 to celebrate a truly outstanding congress – and to remind everyone: the GI and hepatology community will be back in Barcelona for #UEGWeek in October ➡️ https://ueg.eu/week @easlnews.bsky.social​ @joostphdrenth.bsky.social​
🧬 Genetic testing does NOT replace surveillance in #PancreaticCancer Prospective study (n=500) 🔸 Pathogenic variants in 8.8%; 3.4% high-penetrance 🔸 ~50% carriers missed by current criteria 🔸 Cancer can occur without mutations Learn more in UEG Journal: 👉 https://bit.ly/4duoufq
Explore our dedicated #DigestiveHealthMonth page for insights and resources 👉 https://bit.ly/4iN57Ps #EUNewsline
24d
22d
24d
3d
24d
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology
United European Gastroenterology